HUMANIZED 40H3 ANTIBODY
US Application 63/525,493
Filed on 2023-07-07
Filed on 2023-07-07
Method for manufacturing TCR-T cell therapy products targeting tumor antigen(s) from patients with HIV and cancer
US Application 63/469,641
Filed on 2023-05-30
Filed on 2023-05-30
Alvelestat for use in the treatment of graft rejection, bronchiolitis obliterans syndrome and graft versus host disease
US Application 62/901,638
Filed on 2019-09-17
Filed on 2019-09-17
Fully Human Chimeric Antigen Receptors against CD276 for the treatment of solid tumors
US Application 63/514,596
Filed on 2023-07-20
Filed on 2023-07-20
SINGLE DOMAIN ANTIBODIES THAT SPECIFICALLY BIND THE S2 SUBUNIT OF SARS-COV-2 SPIKE PROTEIN AND COMPOSITIONS AND USES THEREOF
US Application 63/501,772
Filed on 2023-05-12
Filed on 2023-05-12
Repurposing Shingrix and Gardasil Immunity in Combination with a Tumor Associated Antigen
US Application 63/497,348
Filed on 2023-04-20
Filed on 2023-04-20
EPIDITHIODIKETOPIPERAZINE ANALOGS AND METHODS OF USE
US Application 63/507,813
Filed on 2023-06-13
Filed on 2023-06-13
ALLOSTERIC INHIBITORS OF THE POLO-LIKE KINASE 1 POLO BOX DOMAIN, PHARMACEUTICAL COMPOSITIONS, AND METHOD OF TREATING CANCER
US Application 63/455,608
Filed on 2023-03-30
Filed on 2023-03-30
T CELL RECEPTORS TARGETING RAS WITH G12D, G12R, OR G12V MUTATION
US Application 63/510,817
Filed on 2023-06-28
Filed on 2023-06-28
V2 PEPTIDE VACCINE FOR HIV-1
US Application 63/492,258
Filed on 2023-03-27
Filed on 2023-03-27